Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
-0.0050 (-25.00%)
At close: Mar 20, 2026

Appili Therapeutics Income Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
0.210.10.830.331.39-
Revenue Growth (YoY)
65.38%-87.86%147.59%-75.97%--
Gross Profit
0.210.10.830.331.39-
Selling, General & Admin
2.462.853.054.444.614.79
Research & Development
3.97.325.623.6220.7410.22
Other Operating Expenses
3.249.96.10.321.771.94
Total Operating Expenses
9.620.0814.768.3927.1316.95
Operating Income
-9.39-19.98-13.94-8.05-25.74-16.95
Interest Income
-00.020.030.030.12
Interest Expense
-1.86-3.5-1.63-1.1-1.55-0.07
Other Non-Operating Income (Expense)
-0.511.74-0.070.36-0.06-
Total Non-Operating Income (Expense)
-2.37-1.76-1.68-0.7-1.580.05
Pretax Income
-11.76-21.74-15.62-8.75-27.32-16.9
Provision for Income Taxes
0.10.020.070.040.04-
Net Income
-2.96-2.62-3.78-9.24-25.12-14.33
Net Income to Common
-2.96-2.62-3.78-9.24-25.12-14.33
Shares Outstanding (Basic)
1281211211146759
Shares Outstanding (Diluted)
1281211211146759
Shares Change (YoY)
5.85%-6.63%70.43%12.76%74.81%
EPS (Basic)
-0.02-0.02-0.03-0.08-0.38-0.24
EPS (Diluted)
-0.02-0.02-0.03-0.08-0.38-0.24
Free Cash Flow
-0.010.87-2.49-10.1-19.08-11.46
Free Cash Flow Per Share
-0.01-0.02-0.09-0.29-0.19
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-4551.33%-19891.16%-1684.49%-2409.73%-1851.00%-
Profit Margin
-5750.94%-21658.88%-1895.93%-2630.56%-1967.23%-
FCF Margin
-5.66%862.63%-301.44%-3022.65%-1372.07%-
EBITDA
-9.38-19.97-13.92-8.05-25.73-16.93
EBITDA Margin
-4546.45%-19877.76%-1682.84%-2407.85%-1850.09%-
EBIT
-9.39-19.98-13.94-8.05-25.74-16.95
EBIT Margin
-4551.33%-19891.16%-1684.49%-2409.73%-1851.00%-
Effective Tax Rate
-0.88%-0.09%-0.45%-0.42%-0.14%0.00%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.